Page 1,612«..1020..1,6111,6121,6131,614..1,6201,630..»

The Equities Research Analysts’ Updated EPS Estimates for March, 20th (AIMT, AMID, AUPH, AVD, BDREF, BPTH … – Petro Global News 24

Posted: March 23, 2017 at 4:43 am

Equities Research Analysts updated eps estimates for Monday, March 20th:

Aimmune Therapeutics (NASDAQ:AIMT) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, Aimmune Therapeutics, Inc. is a biopharmaceutical company which is engaged in the development of desensitization treatments for peanut and other food allergies. The Companys characterized oral desensitization immunotherapy includes AR101, a product for the treatment of peanut allergy in children and adults which is in clinical trial stage. Aimmune Therapeutics, Inc. is headquartered in Brisbane, California.

American Midstream Partners (NYSE:AMID) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, American Midstream Partners, LP owns, operates, develops and acquire a diversified portfolio of natural gas midstream energy assets. The Company is engaged in the business of gathering, treating, processing and transporting natural gas through its ownership and operation of gathering systems, processing facilities and pipelines. Its primary assets, which are located in Alabama, Louisiana, Mississippi, Tennessee and Texas, provide infrastructure that links producers and suppliers of natural gas to diverse natural gas markets, including various pipelines, as well as utility, industrial and other commercial customers. American Midstream Partners, LP is based in Denver, Colorado.

Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The companys lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

American Vanguard Corp. (NYSE:AVD) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, AMERICAN VANGUARD CORP. is a holding company, which through its subsidiaries, is engaged in the manufacturer and formulation of chemicals for crops, human and animal health protection. These chemicals which include insecticides, fungicides, molluscicides, growth regulatorsain, and soil fumigants, are marketed in liquid, powder, and granular forms.

Beadell Resources (NASDAQ:BDREF) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, Beadell Resources Limited is a gold producer. It owns and operates the Tucano gold mine primarily in Brazil. Beadell Resources Limited is based in West Perth, Australia.

Bio-Path Holdings (NASDAQ:BPTH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $0.75 target price on the stock. According to Zacks, BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development. Bio-Paths drug delivery technology distributes nucleic acid drugs systemically, throughout the human body, via simple intravenous infusion. The delivery technology can be applied both to double stranded and single stranded nucleic acid compounds with the potential to revolutionize the treatment of cancer and other diseases where drugable targets of disease are well characterized.

COBHAM (NASDAQ:CBHMY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, Cobham Plc is engaged in designing and manufacturing equipment as well as components for defence and security, aerospace, space, marine and electronic industries. It primarily operates through segments which include Communications and Connectivity, Advanced Electronic Solutions, Mission Systems and Aviation Services. The Communications and Connectivity segment provides communication equipment, law enforcement and national security solutions and satellite communication equipment for land, sea and air applications. The Advanced Electronic Solutions segment provides technology and solutions for intelligence operations and systems to communicate on land, sea and air. The Mission Systems segment provides safety and survival systems for environments, weapons carriage and equipment for fast jets, transport aircraft, rotor craft, remote controlled robots and bomb disposal vehicles for military application. The Aviation Services segment provides outsourced aviation services for military and civil customers as well as

CBL & Associates Properties (NYSE:CBL) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, CBL & Associates Properties, Inc. is a fully integrated real estate investment trust which owns, develops, acquires, leases, manages, and operates regional shopping malls, open-air centers, community centers and office properties. The Company conducts substantially all of its business through its operating partnership. It owns two qualified REIT subsidiaries: CBL Holdings I, Inc. and CBL Holdings II, Inc. CBL & Associates Properties is headquartered in Chattanooga, Tennessee.

Carnival Corp (NYSE:CCL) was upgraded by analysts at William Blair from a market perform rating to an outperform rating.

China Unicom (Hong Kong) Limited (NYSE:CHU) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a buy rating. The firm currently has $15.00 price target on the stock. According to Zacks, China Unicom Limited is engaged in the provision of cellular, paging, long distance, data and internet services in the Peoples Repulic of China.

Catalyst Pharmaceuticals (NASDAQ:CPRX) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $6.00 target price on the stock.

Carrefour Sa Spon (NASDAQ:CRRFY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, Carrefour S.A. operates hypermarkets, supermarkets, convenience stores and cash and carry stores in Europe, the Americas and Asia. Carrefour S.A. is headquartered in Boulogne-Billancourt, France.

Cytori Therapeutics (NASDAQ:CYTX) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, Cytori Therapeutics, Inc. is discovering and developing proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue, also known as fat. The Companys preclinical investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders, and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose stem and regenerative cells, Cytori has developed its proprietary Celution System to isolate and concentrate a patients own stem and regenerative cells in about an hour. This system will dramatically improve the speed in which personalized cell-based therapies can be delivered to patients.

Countrywide (NASDAQ:CYWDF) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, Countrywide plc provides property services which includes estate agency and lettings network. The companys business unit consists of Retail, London, B2B and Financial Services. Countrywide plc is headquartered in Milton Keynes, the United Kingdom.

Tableau Software (NYSE:DATA) had its buy rating reiterated by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $70.00 price target on the stock.

Evoke Pharma (NASDAQ:EVOK) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Companys lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.

POWERSHARES GLBAL FUNDS IRELAND PLC POWERSHARES EQQQ NASDAQ-100 UCITS ETF (NASDAQ:IRELAND) was upgraded by analysts at Wells Fargo & Co from a market perform rating to an outperform rating.

JPMorgan Chase & Co. (NYSE:JPM) had its overweight rating reaffirmed by analysts at Barclays PLC. The firm currently has a $100.00 target price on the stock.

Starbucks (NASDAQ:SBUX) had its outperform rating reiterated by analysts at Wells Fargo & Co. Wells Fargo & Co currently has a $65.00 target price on the stock.

Steel Dynamics (NASDAQ:STLD) had its neutral rating reiterated by analysts at Macquarie.

See the original post:
The Equities Research Analysts' Updated EPS Estimates for March, 20th (AIMT, AMID, AUPH, AVD, BDREF, BPTH ... - Petro Global News 24

Posted in Alabama Stem Cells | Comments Off on The Equities Research Analysts’ Updated EPS Estimates for March, 20th (AIMT, AMID, AUPH, AVD, BDREF, BPTH … – Petro Global News 24

BIO Announces Plenary Sessions for 2017 World Congress on … – Business Wire (press release)

Posted: March 23, 2017 at 4:42 am

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Innovation Organization (BIO) today released the list of speakers for plenary programs at the2017 World Congress on Industrial Biotechnology. The sessions will feature executives from the biofuels, household and personal care, and airline industries who will discuss technology breakthroughs, business partnerships and sustainability initiatives. The worlds largest industrial biotechnology event will be held July 23-26, 2017 at the Palais des congrs de Montral in Montral, Qubec, Canada.

Brent Erickson, Executive Vice President, Industrial and Environmental at BIO, stated, The Plenary Program for the 2017 World Congress will cover several novel topics that are emerging within the industry. Panelists will provide an overview of the current state of biobased food ingredients, flavorings, and personal care products and where market trends are headed in the future. Additionally, industry representatives and trade reporters will discuss how to meaningfully communicate about the biobased economy.

Some highlighted Plenary Sessions include:

Biotech and the Future of Food Ingredients, Flavorings, and Personal Care Monday, July 24, 2017 3:45 pm - 5:00pm

Speakers:

Second Generation Biofuels Poised for Big Wins Tuesday, July 25, 2017 8:30 am - 10:00am

Moderator:Jim Lane, Editor and Publisher, The Digest Speakers:

Effectively Communicating the Benefits of Industrial Biotechnology Tuesday, July 25, 2017 11:45 am 1:30 pm

Moderator:Rebecca Coons, Senior Editor, Chemical Week, IHS Chemical Speakers:

All programs at the World Congress on Industrial Biotechnology are open to attendance by members of the media. Complimentarymedia registrationis available to editors and reporters working full time for print, broadcast or web publications with valid press credentials.

For more information on the conference please visithttp://www.bio.org/worldcongress. For assistance, please contactworldcongress@bio.org.

About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces theBIO International Convention, the worlds largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.BIOtechNOWis BIO's blog chronicling innovations transforming our world and the BIO Newsletter is the organizations bi-weekly email newsletter.Subscribe to the BIO Newsletter.

Upcoming BIO Events

BIO-Europe Spring Conference March 20-22, 2017 Barcelona, Spain

BIO IP Counsels Committee Conference March 27-29, 2017 Newport Beach, CA

BIO International Convention June 19-22, 2017 San Diego, CA

BIO World Congress on Industrial Biotechnology July 23 - 26, 2017 Montral, Canada

Read the original post:
BIO Announces Plenary Sessions for 2017 World Congress on ... - Business Wire (press release)

Posted in Biotechnology | Comments Off on BIO Announces Plenary Sessions for 2017 World Congress on … – Business Wire (press release)

Lookout for Price Target? EP Energy Corporation (EPE), Puma … – StockNewsJournal

Posted: March 23, 2017 at 4:42 am


StockNewsJournal

See the rest here:
Lookout for Price Target? EP Energy Corporation (EPE), Puma ... - StockNewsJournal

Posted in Biotechnology | Comments Off on Lookout for Price Target? EP Energy Corporation (EPE), Puma … – StockNewsJournal

Plasma and stem cells: The future of regenerative medicine | WEAR – WEAR

Posted: March 23, 2017 at 4:42 am

Plasma and stem cells: The future of regenerative medicine

Blood platelet injections and stem cell treatments may sound like the future, but physicians at the Andrews Institute are already practicing these forms of regenerative medicine.

Weight lifting mixed with normal wear and tear left Howie Webber in constant pain.

"I probably felt it about four months ago," said Howie. "I did some stretching, thinking I could make it go away, but it just continued to get worse."

That's when Howie went to the doctor and found out he had two options: surgery or regenerative medicine; he picked the latter.

"I just added up the amount of time I'd be out of work and the cost of surgery, plus the copay and this whole thing just seemed like it would be a little faster and a little easier, and it ended up being just that," said Howie.

Physicians at the Andrew's Institute currently offer two different types of regenerative medicine, platelet rich plasma, or PRP and bone marrow aspirate concentrate, or BMAC.

With PRP, physicians take the patient's blood, separate the platelets and inject those platelets back into the patient at the site of injury. The idea is that platelets carry growth factors and molecules to stimulate the healing process.

BMAC utilizes platelets too, but also the patient's bone marrow harvested from the pelvis.

Both regenerative medicine methods have benefits, perhaps the biggest according to Dr. Brett Kindle, is avoiding invasive surgeries.

"If we need surgery, we need surgery, and that's what it is, but if we can avoid it, that often times is very beneficial from a financial standpoint, missing less work, etc.," said Dr. Kindle. "Also from a quality of life, to be able to get back to doing activities in a more timely manner."

The main difference between the two is price and neither are covered by insurance. BMAC costs upwards of $3,000, while PRP costs anywhere from $600 to $800. Howie opted for PRP.

"It hurt for about three days, then within a week I was pain free," said Howie. "Maybe a little discomfort that you would expect, but it wasn't near as bad as it was before."

Howie's issue was with his hamstrings, but Dr. Kindle said both PRP and BMAC can be used to treat a variety of aches and pains.

"Anything in the limbs," said Dr. Kindle. "Shoulders, elbows, hands, wrists, hips, knees, foot, ankle, all of those areas."

Recovery for both PRP and BMAC procedures is typically one to two weeks. Full effects of the injections don't usually kick in until six to eight weeks later. For more information about regenerative medicine or to schedule a consultation with an Andrews Institute physician, call (850) 916-8700.

Continued here:
Plasma and stem cells: The future of regenerative medicine | WEAR - WEAR

Posted in Cell Medicine | Comments Off on Plasma and stem cells: The future of regenerative medicine | WEAR – WEAR

Three-pronged approach is key to precision medicine – Cornell Chronicle

Posted: March 23, 2017 at 4:42 am

Combining genetic information from a patients tumor cells with three-dimensional cell cultures grown from these tumors and rapidly screening approved drugs can identify the best treatment approaches in patients for whom multiple therapies have failed, according to a new study led by Weill Cornell Medicine investigators.

Published March 22 in Cancer Discovery, the study brings researchers one step closer to fulfilling the promise of precision medicine, which aims to provide targeted, individualized treatment based on each patients genetic profile.

Our goal is to use precision medicine to improve the way clinicians think about cancer therapies as opposed to selecting a therapy that may not be fitted to that patients cancer, said senior author Dr. Mark Rubin, director of the Englander Institute for Precision Medicine and the Homer T. Hirst III Professor of Oncology in Pathology at Weill Cornell Medicine, and director of the joint precision medicine program at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center. Combining genome sequencing with rapid drug screening enables us to nominate new therapies for patients, which we could not have predicted from the genomics alone.

Cancer genetics research has made great strides in the last 20 years, allowing investigators to now identify mutations in tumor cells that are susceptible to treatment. Still, a significant number of cases remain in which genetic mutations cannot indicate to clinicians exactly what drug will be effective in treating a patients disease, particularly for those with advanced cancers that have failed multiple therapies.

To better treat these patients, Rubin and the research team including co-first authors Dr. Chantal Pauli, a former research fellow in Rubins lab, and Benjamin Hopkins, a postdoctoral associate in co-author Dr. Lewis C. Cantleys lab developed an approach in which tumor cells taken from patients are grown into three-dimensional cell cultures called tumor-derived organoids. The researchers can then test more than 120 U.S. Food and Drug Administration-approved cancer drugs against the organoids to determine which drugs show the most promise. After identifying a potential treatment, they transplant the organoid into a mouse to assess how well the tumor responds to the drug. The organoid cell culture system, Rubin said, markedly accelerates the identification of potential therapies compared with current approaches, which depend on growing tumor cells in mice.

With the organoid system, we can obtain answers in one to two months, compared to six months to a year with mice, Rubin said. This is critically important for patients with advanced cancer. We need to strive to identify new and more effective therapies in a timely manner.

Dramatic improvements in the ability to grow tumors as organoids outside the body is bringing precision medicine to the next level of precision, added Cantley, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. It is now possible to grow a wide variety of tumors outside of the body; this allows the precision medicine team to not only obtain full exome and RNA sequencing data, but also test a panel of approved drugs on the same tumor that is growing in the patient. Importantly, this can occur within a time scale that would allow one to make a clinical decision about the next therapy, should the tumor progress on standard of care.

This approach could revolutionize how cancers are treated in the future, he said, by providing oncologists with detailed information about the genetic aberrations, the gene expression profiles and the response to drugs of the same tumor that is growing in the patient.

For the study, researchers analyzed tumor-derived cells from four patients who came to the Englander Institute for care. Two of the patients had different forms of uterine cancer, while the other two had different forms of colon cancer. The scientists identified effective drugs and drug combinations many of which are medications approved for treating other cancers that they subsequently validated using organoid cultures and organoids transplanted into mice.

Specifically, the researchers discovered that the combination of two breast cancer drugs could treat one of the uterine cancer cases. For the other, one of the top treatments was a combination of a breast cancer drug and a lymphoma drug.

The investigators found that a colon cancer drug combined with one approved for metastatic melanoma could treat one of the colon cancer cases; they believe their results could establish a basis for a clinical trial. For the other colon cancer case, the scientists identified a therapy that combines a lung cancer drug with one approved for treating blood cancers such as lymphoma and multiple myeloma.

At the moment, there is no standard to guide a clinicians decision of when to give a patient a drug thats not recommended by the FDA, Rubin said. With this study, were trying to establish a standard that uses a patients cells to answer that question.

This study was supported in part by the National Institutes of Health, the Starr Cancer Consortium and the Prostate Cancer Foundation.

Joseph Bonner is a freelance writer for Weill Cornell Medicine.

Excerpt from:
Three-pronged approach is key to precision medicine - Cornell Chronicle

Posted in Cell Medicine | Comments Off on Three-pronged approach is key to precision medicine – Cornell Chronicle

Stem cell therapy could help mend the youngest of broken hearts – Medical Xpress

Posted: March 23, 2017 at 4:41 am

March 21, 2017 Credit: University of Bristol

Researchers have shown stem cells from the umbilical cord may hold the key to a new generation of graft and could reduce the number of surgeries required to treat young children born with certain types of congenital heart disease.

Congenital heart disease (CHD) is the most common type of birth defect. In the UK alone over 4,000 babies are diagnosed with CHD each year and thanks to advances in treatment and care, more than eight out of ten CHD babies grow up to be adults.

However, the only treatment for these conditions is corrective surgery where a piece of tissue, known as an implant, is used to replace the damaged area. Often surgery has to be repeated several times throughout childhood as the child's heart outgrows the artificial implant used to repair it.

Professors Massimo Caputo and Paolo Madeddu, in the Bristol Heart Institute, a newly created specialist research institute (SRI) at the University of Bristol, have developed cellular grafts using stem cells from the umbilical cord and placenta that are able to grow like living tissue and it is hoped would be able to grow along with a child's heart. These new grafts would mean that instead of having multiple operations to insert bigger grafts as the patient's heart grows only one operation would be needed.

These grafts have been tested in animal models that closely resemble the 'real-world' scenario and tested for their capacity to grow and regenerate the damaged heart. The researchers are also exploring which cells are best suited for the graft so that a wide range of treatment options and solutions could be tailored to the patients' needs. With the first two phases of research completed, the academics are now preparing to start a clinical trial in newborn babies.

Massimo Captuo, Professor of Congenital Heart Surgery from the School of Clinical Sciences, said: "We believe stem cells from the umbilical cord, usually discarded after birth, could hold the key to a new generation of graft. These grafts grow at the same rate as the children they're used to treat and reduce the risk of rejection after transplant as they contain the child's own DNA."

Paolo Madeddu, Professor of Experimental Cardiovascular Medicine from the School of Clinical Sciences, added: "The long-term outcomes for most young children remains poor and significantly affects their quality of life. By developing these new grafts, we hope to reduce the amount of surgeries that a child born with congenital heart disease must go through."

Explore further: Engineered blood vessels grow in lambs

In a hopeful development for children born with congenital heart defects, scientists said Tuesday they had built artificial blood vessels which grew unaided when implanted into lambs, right into adulthood.

Current cardiovascular valve or blood vessel implants are generally associated with a number of complications, have limited efficacy over time, and may necessitate repeated interventions over a patient's lifetime, especially ...

Mayo Clinic has announced the first U.S. stem cell clinical trial for pediatric congenital heart disease. The trial aims to determine how stem cells from autologous umbilical cord blood can help children with hypoplastic ...

In a first-in-children randomized clinical study, medical researchers at the University of Maryland School of Medicine (UM SOM) and the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School ...

Over one million children are born with congenital heart disease (CHD) each year. When children with CHD receive timely treatment, 85% can survive into adulthood to live healthy, productive lives. Sadly, 90% of the children ...

A new minimally invasive technique for repairing the most common cardiac birth defect in extremely premature newborns can be performed safely with a high success rate in babies as small as 755 grams - about 1.6 pounds - only ...

Moderate drinking is associated with a lower risk of several, but not all, cardiovascular diseases, finds a large study of UK adults published by The BMJ today.

A small protein that could protect the brain from stroke-induced injury has been discovered by researchers from The University of Queensland and Monash University.

ATMs and coffee shops such as Tim Hortons, Starbucks and Second Cup make ideal locations for placing automated external defibrillators (AEDs), according to a new study led by U of T Engineering researchers Professor Timothy ...

About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood clots around the valve leaflets (known as subclinical leaflet thrombosis) that reduced the motion of the valves, according to ...

Substituting rivaroxaban for aspirin in patients with acute coronary syndromes (ACS) appears to cause no significant increase in bleeding risk, according to a study led by scientists from the Duke Clinical Research Institute ...

Researchers are revisiting their views on the relative dangers soft and hard atherosclerotic plaque deposits pose to heart health. Findings of a new study by researchers at the Intermountain Medical Center Heart Institute ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

View post:
Stem cell therapy could help mend the youngest of broken hearts - Medical Xpress

Posted in Cell Therapy | Comments Off on Stem cell therapy could help mend the youngest of broken hearts – Medical Xpress

Media Touts A New Study Blaming Diabetes Epidemic On Global Warming – Daily Caller

Posted: March 23, 2017 at 4:40 am

5547332

The media is touting a new study claiming global warming could be, at least in part, to blame for the diabetes epidemic sweeping the globe.

When it gets warmer, there is higher incidence of diabetes, Lisanne Blauw, a Ph.D. candidate at the Netherlands-based Einthoven Laboratory and the studys lead author, told The Huffington Post Tuesday.

Its important to realize global warming has further effects on our health, not only on the climate, Blauw said.

Blauw and her colleagues wrote the diabetes incidence rate in the USA and prevalence of glucose intolerance worldwide increase with higher outdoor temperature based on a meta-analysis of 14 years of data on diabetes and temperature in U.S. states.

Researchers hypothesize the global increase in temperature contributes to the current type 2 diabetes epidemic since warmer weather could inhibit brown adipose tissue (BAT) that turns food into energy for the body.

That could reduce the bodys ability to metabolize glucose, making Type 2 diabetes more likely.

Hot weather can be more difficult for people with diabetes, Mona Sarfaty, director of the Consortium on Climate Change and Health, told Popular Science.

The heat keeps people from being active, which means they expend less calories, which can lead to more weight gain, Sarfaty said. Also, people with diabetes often have kidney problems. Dehydrationwhich comes with heatcan worsen kidney problems when people are dehydrated.

HuffPo, of course, mentioned climate scientists declared 2016 the hottest year on record.

On the basis of our results, a 1C rise in environmental temperature would account for over 100000 new diabetes cases per year in the USA alone, given a population of nearly 322 million people in 2015, Blauw and her colleagues wrote.

Sounds terrifying, until you get into the data. Blauw and her colleagues even state that causality between temperature and diabetes cant be drawn from their meta-analysis.

The associative design of our study does not allow us to draw conclusions on causality, the researchers wrote.

Also, the way the study measured diabetes prevalence is based on self-reported surveys collected by the U.S. government. That survey asks people if a doctor told them they had diabetes in the last year it does not get actual diagnosis data from medical professionals.

Blauws study examines self-reported diabetes in the U.S.from 1996 to 2009, but right at the beginning of the study period medical professionals relaxed the definition of what constitutes diabetes.

The National Institutes of Health noted in 1998 that these changes are likely to lead to an increase in the prevalence of diagnosed diabetes as it would become practically much easier to detect the large number of people whose disease is currently undiagnosed.

On a more basic level, though, Blauws meta-analysis masks a confounding phenomenon. Many states actually showed a decrease in diabetes incidence rate as temperatures rose.

How can warm weather cause more incidents diabetes in South Carolina, but fewer in Louisiana? Not all researchers agreed with the studys findings.

I think calorie consumption and weight are probably the biggest by a country mile, Adrian Vella, an endocrinologist who was not involved in the new study, told CNN.

I think the general message always should be that association studies do not actually imply causation, Vella said.

Follow Michael on Facebook and Twitter

Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact [emailprotected].

Follow this link:
Media Touts A New Study Blaming Diabetes Epidemic On Global Warming - Daily Caller

Posted in Diabetes | Comments Off on Media Touts A New Study Blaming Diabetes Epidemic On Global Warming – Daily Caller

Jackson County Health Offficials Offer Diabetes Prevention – My Panhandle

Posted: March 23, 2017 at 4:40 am

MARIANNA, Fla. -

On the heels of 'Diabetes Alert Day' next Tuesday, Jackson County Health officials want to make residents more aware of the diabetes epidemic facing this nation.

The Florida Department of Health in Jackson County and the county's University of Florida Extension Office are offering free diabetes prevention classes at the Jackson County Library in Marianna.

"We're at about a 50 percent for individuals diagnosed with Type 2 diabetes," said Jackson County FDOH Senior Human Services Program Specialist, Mary Gurganus.

Lifestyle coaches Marie Arick and Mary Gurganus started the 'Type Two Diabetes Prevention' program a month ago.

Some of the program's goals include increasing physical fitness recommended by the Center for Disease Control (CDC).

"The program goals are to lose five to seven percent of your current body weight to achieve a healthier weight and then to increase physical activity," said Gurganus.

"It worked to our benefit for us to be able to partner so that we would always have someone available to be able to support these people that come in to the community to participate," added Arick.

The year-long session also includes dietary tips.

"Those small lessons have a huge impact. And if you go home and you apply just a portion of each lesson, you gain a great benefit," said Arick.

"We want everyone to be able to sustain the lifestyle changes that they've chose for continued success," said Gurganus.

Both lifestyle coaches said the partnership will better serve the county.

"We'd like to keep those rates as low as possible and have those individuals with pre-diabetes not progress to diabetes," said Gurganus.

Arick and Gurganus said the American Diabetes Association awarded them $3,500 in grants towards the program.

Residents can call the UF Extension Office at 850-9620, or the Florida Department of Health in Jackson County at 850-526-2412.

The rest is here:
Jackson County Health Offficials Offer Diabetes Prevention - My Panhandle

Posted in Diabetes | Comments Off on Jackson County Health Offficials Offer Diabetes Prevention – My Panhandle

Diabetes researchers discover way to expand potent regulatory cells – Science Daily

Posted: March 23, 2017 at 4:40 am

Diabetes researchers discover way to expand potent regulatory cells
Science Daily
The findings involve thymic regulatory T cells, a type of white blood cell that modulates the immune system and prevents autoimmune diseases such as Type 1 diabetes. The finding -- showing that so-called Tregs can be frozen at birth and later ...

and more »

Visit link:
Diabetes researchers discover way to expand potent regulatory cells - Science Daily

Posted in Diabetes | Comments Off on Diabetes researchers discover way to expand potent regulatory cells – Science Daily

San Antonio launches new campaign to fight diabetes and obesity – mySanAntonio.com

Posted: March 23, 2017 at 4:40 am

Photo: Donald Iain Smith, Getty Images/Flickr RF

Click ahead to view the healthiest cities in Texas, according to WalletHub.

Click ahead to view the healthiest cities in Texas, according to WalletHub.

Texas is home to four of the least healthy cities in the U.S., according to a new list from WalletHub.

Click through the slideshow to see how 16 Texas cities stacked up against one another.

Texas is home to four of the least healthy cities in the U.S., according to a new list from WalletHub.

Click through the slideshow to see how 16 Texas cities stacked up against one another.

Health Care Rank: 117 Food Rank: 150 Fitness Rank: 143 Green Space Rank: 145

Health Care Rank: 117 Food Rank: 150 Fitness Rank: 143 Green Space Rank: 145

Health Care Rank: 43 Food Rank: 146 Fitness Rank: 149 Green Space Rank: 127

Health Care Rank: 43 Food Rank: 146 Fitness Rank: 149 Green Space Rank: 127

Health Care Rank: 130 Food Rank: 143 Fitness Rank: 133 Green Space Rank: 132

Health Care Rank: 130 Food Rank: 143 Fitness Rank: 133 Green Space Rank: 132

13. El Paso (139 overall)Health Care Rank: 116 Food Rank: 137 Fitness Rank: 117 Green Space Rank: 124

13. El Paso (139 overall)Health Care Rank: 116 Food Rank: 137 Fitness Rank: 117 Green Space Rank: 124

Health Care Rank: 84 Food Rank: 112 Fitness Rank: 115 Green Space Rank: 142

Health Care Rank: 84 Food Rank: 112 Fitness Rank: 115 Green Space Rank: 142

Health Care Rank: 106 Food Rank: 91 Fitness Rank: 108 Green Space Rank: 146

Health Care Rank: 106 Food Rank: 91 Fitness Rank: 108 Green Space Rank: 146

Health Care Rank: 88 Food Rank: 138 Fitness Rank: 121 Green Space Rank: 82

Health Care Rank: 88 Food Rank: 138 Fitness Rank: 121 Green Space Rank: 82

Health Care Rank: 87 Food Rank: 103 Fitness Rank: 114 Green Space Rank: 138

Health Care Rank: 87 Food Rank: 103 Fitness Rank: 114 Green Space Rank: 138

Health Care Rank: 86 Food Rank: 97 Fitness Rank: 100 Green Space Rank: 129

Health Care Rank: 86 Food Rank: 97 Fitness Rank: 100 Green Space Rank: 129

Health Care Rank: 104 Food Rank: 67 Fitness Rank: 118 Green Space Rank: 134

Health Care Rank: 104 Food Rank: 67 Fitness Rank: 118 Green Space Rank: 134

Health Care Rank: 90 Food Rank: 83 Fitness Rank: 144 Green Space Rank: 105

Health Care Rank: 90 Food Rank: 83 Fitness Rank: 144 Green Space Rank: 105

Health Care Rank: 63 Food Rank: 130 Fitness Rank: 58 Green Space Rank: 113

Health Care Rank: 63 Food Rank: 130 Fitness Rank: 58 Green Space Rank: 113

Health Care Rank: 81 Food Rank: 62 Fitness Rank: 106 Green Space Rank: 114

Health Care Rank: 81 Food Rank: 62 Fitness Rank: 106 Green Space Rank: 114

Health Care Rank: 103 Food Rank: 72 Fitness Rank: 111 Green Space Rank: 99

Health Care Rank: 103 Food Rank: 72 Fitness Rank: 111 Green Space Rank: 99

Health Care Rank: 30 Food Rank: 21 Fitness Rank: 56 Green Space Rank: 33

Health Care Rank: 30 Food Rank: 21 Fitness Rank: 56 Green Space Rank: 33

Health Care Rank: 9 Food Rank: 37 Fitness Rank: 24 Green Space Rank: 42

Health Care Rank: 9 Food Rank: 37 Fitness Rank: 24 Green Space Rank: 42

San Antonio launches new campaign to fight diabetes and obesity

In the battle against diabetes and obesity two health scourges that are rampant in Bexar County the citys health department just started a new campaign centered on healthy eating.

The San Antonio Metropolitan Health Districts Viva Health! nutrition education drive aims to blanket the city with information on what constitutes a nourishing diet, and how individuals and families can go about replacing bad meals with good ones, in the easiest, most cost-effective ways possible.

It is based on three simple messages:

Fill half your plate with fruits and vegetables, every meal, every day

For portion control, use a smaller plate think salad plate

Drink water, not sugary drinks

The education push aims to reverse statistics that show nearly 11 percent of Bexar County adults were diagnosed with diabetes in 2015. That data includes only those whove been told by a doctor they had the disease, so the actual number is likely much higher, said Metro Health officials. More than one-third of adults in Bexar County were classified as obese in 2015. Obesity, unhealthy on its own, is also a risk factor for diabetes, which carries a host of serious health complications, including kidney failure, blindness and stroke.

At a news conference announcing the new campaign, Mayor Ivy Taylor said the program fits in perfectly with the Mayors Fitness Council, which aims to make San Antonio one of the healthiest and most active cities in the nation. Taylor told of her own struggle in convincing her 13 year-old daughter and husband both meat and potatoes fans to choose healthier foods.

Sometimes I get home late after dinner and I find the remnants of fast-food meals in the kitchen, she said. Its a common refrain for me at home, Eat some fruit with that! Get some apple sauce or mandarin oranges!

Many neighborhoods in San Antonio continue to struggle with access to nourishing food, Taylor said, especially high-poverty areas. The new campaign the tag line is eat well, to feel great should help with that, she said.

Metro Health, in partnership with the San Antonio Food Bank, the Culinary Education for Families (CHEF) program and other community groups, plans to conduct a marketing campaign using the visual image of a plate with the right proportion of fruits, vegetables, grains and protein. Metro Healths WIC and Healthy Neighborhoods program will provide nutrition classes and community outreach using the image and the three core messages.

The Mayors Fitness Council plans to promote the message within its programs, such as including it within material provided to physicians offices in underserved areas and in tool kits to faith-based organizations. The CHEF program, an innovative cooking school founded by the Goldsbury Foundation and the Childrens Hospital of San Antonio, is co-developing a web-based and hard-copy interactive meal planning tool that uses the image and the core messages. The online tool will link users to simple and affordable recipes on the CHEF website.

The food banks Mobile Mercado is going to help food-insecure residents meet the daily goal of healthy eating proportions, by providing education campaign materials during their community nutrition and cooking classes across the county, said Michael Guerra, spokesman for the organization.

Colleen Bridger, in her third week as the new director of Metro Health, said shes starting to understand the challenges San Antonio faces in terms of chronic diseases like obesity and diabetes.

There are many contributing factors, but how we eat is a key issue, she said. There are challenging circumstances and environments that make the healthy choice not an easy choice. This campaign gives us the tools we need to really address the problem.

mstoeltje@express-news.net

Read more from the original source:
San Antonio launches new campaign to fight diabetes and obesity - mySanAntonio.com

Posted in Diabetes | Comments Off on San Antonio launches new campaign to fight diabetes and obesity – mySanAntonio.com

Page 1,612«..1020..1,6111,6121,6131,614..1,6201,630..»